Cambium Bio Ltd (CMB) — Cash Flow Quality Index
Cambium Bio Ltd (CMB) has a Cash Flow Quality Index of -0.82x as of March 2023. Operating cash flow of AU$-308.70K is below net income of AU$374.44K, suggesting accrual-heavy earnings not yet converted to cash. Explore Cambium Bio Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cambium Bio Ltd Cash Flow Quality Index (1999–2021)
Historical Cash Flow Quality Index for Cambium Bio Ltd across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Cambium Bio Ltd generate cash.
Annual Cash Flow Quality Index for Cambium Bio Ltd (1999–2021)
Year-by-year earnings quality comparison for Cambium Bio Ltd.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | 0.88x | AU$2.42 Million | AU$2.76 Million | ▼ -20.1% |
| 2017 | 1.10x | AU$3.59 Million | AU$3.27 Million | ▼ -41.5% |
| 2001 | 1.88x | AU$38.20 Million | AU$20.36 Million | ▲ +6.6% |
| 2000 | 1.76x | AU$48.26 Million | AU$27.42 Million | ▼ -20.8% |
| 1999 | 2.22x | AU$33.43 Million | AU$15.03 Million | — |